Rxo reported revenue of $1774.00M and net income of -$9.00M for the quarter ended Jun 2026, up 25.0% year over year. This income statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||
| Revenue | 1,198.00M | 1,327.00M | 1,312.00M | 1,226.00M | 1,138.00M | 1,120.00M | 1,010.00M | 963.00M | 976.00M | 978.00M | 913.00M | 930.00M | 1,040.00M | 1,667.00M | 1,433.00M | 1,419.00M | 1,421.00M | 1,469.00M | 1,425.00M | 1,774.00M |
| Cost of RevenueCost of Rev | 958.00M | 1,051.00M | 1,021.00M | 904.00M | 857.00M | 842.00M | 759.00M | 723.00M | 742.00M | 743.00M | 699.00M | 700.00M | 809.00M | 1,357.00M | 1,153.00M | 1,118.00M | 1,137.00M | 1,203.00M | 1,171.00M | 1,472.00M |
| Gross Profit | 240.00M | 276.00M | 291.00M | 322.00M | 281.00M | 278.00M | 251.00M | 240.00M | 234.00M | 235.00M | 214.00M | 230.00M | 231.00M | 310.00M | 280.00M | 301.00M | 284.00M | 266.00M | 254.00M | 302.00M |
| Operating items | ||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 130.00M | 152.00M | 161.00M | 166.00M | 158.00M | 155.00M | 153.00M | 144.00M | 148.00M | 146.00M | 145.00M | 154.00M | 149.00M | 218.00M | 210.00M | 214.00M | 208.00M | 200.00M | 197.00M | 211.00M |
| Restructuring CostsRestructuring | 1.00M | 1.00M | 3.00M | 6.00M | 4.00M | 8.00M | 1.00M | 3.00M | 4.00M | 11.00M | 2.00M | 2.00M | 18.00M | 14.00M | 3.00M | 4.00M | 17.00M | 7.00M | 7.00M | |
| Operating ExpensesOpex | 131.00M | 153.00M | 161.00M | 169.00M | 164.00M | 159.00M | 161.00M | 145.00M | 151.00M | 150.00M | 156.00M | 156.00M | 151.00M | 236.00M | 224.00M | 217.00M | 212.00M | 217.00M | 204.00M | 218.00M |
| Operating IncomeOp. Inc | 38.00M | 55.00M | 51.00M | 58.00M | 15.00M | -1.00M | 5.00M | 14.00M | 6.00M | 14.00M | -12.00M | -20.00M | -24.00M | -30.00M | -7.00M | -42.00M | -28.00M | 1.00M | ||
| EBIT | 38.00M | 55.00M | 51.00M | 58.00M | 15.00M | -1.00M | 5.00M | 14.00M | 6.00M | 14.00M | -12.00M | -20.00M | -24.00M | -30.00M | -7.00M | -42.00M | -28.00M | 1.00M | ||
| Non-operating items | ||||||||||||||||||||
| Non Operating Interest Expenses | 1.00M | |||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 1.00M | -5.00M | -8.00M | -8.00M | -8.00M | -8.00M | -8.00M | -8.00M | -6.00M | -8.00M | -9.00M | -8.00M | -9.00M | -9.00M | -9.00M | -9.00M | ||||
| Other Non Operating IncomeOther Non Op Inc. | -1.00M | -1.00M | -216.00M | -2.00M | 1.00M | -11.00M | ||||||||||||||
| Net income details | ||||||||||||||||||||
| EBT | 38.00M | 55.00M | 51.00M | 59.00M | 15.00M | -6.00M | -3.00M | 6.00M | -3.00M | 4.00M | -21.00M | -8.00M | -242.00M | -33.00M | -39.00M | -10.00M | -15.00M | -51.00M | -49.00M | -8.00M |
| Tax ProvisionsTaxes | 5.00M | 13.00M | 12.00M | 15.00M | 2.00M | -2.00M | -3.00M | 3.00M | -2.00M | 2.00M | -6.00M | -1.00M | 1.00M | -8.00M | -8.00M | -1.00M | -1.00M | -5.00M | -13.00M | 1.00M |
| Profit After TaxPAT | 33.00M | 42.00M | 39.00M | 44.00M | 13.00M | -4.00M | 3.00M | -1.00M | 2.00M | -15.00M | -7.00M | -243.00M | -25.00M | -31.00M | -9.00M | -14.00M | -46.00M | -36.00M | -9.00M | |
| Income from Continuing OperationsIncome (Continuing) | 33.00M | 42.00M | 39.00M | 44.00M | 13.00M | -4.00M | 3.00M | -1.00M | 2.00M | -15.00M | -7.00M | -243.00M | -25.00M | -31.00M | -9.00M | -14.00M | -46.00M | -36.00M | -9.00M | |
| Consolidated Net IncomeConsol Net Inc. | 33.00M | 42.00M | 39.00M | 44.00M | 13.00M | -4.00M | 3.00M | -1.00M | 2.00M | -15.00M | -7.00M | -243.00M | -25.00M | -31.00M | -9.00M | -14.00M | -46.00M | -36.00M | -9.00M | |
| Income towards Parent CompanyParent Net Inc | 33.00M | 42.00M | 39.00M | 44.00M | 13.00M | -4.00M | 3.00M | -1.00M | 2.00M | -15.00M | -7.00M | -243.00M | -25.00M | -31.00M | -9.00M | -14.00M | -46.00M | -36.00M | -9.00M | |
| Net Income towards Common StockholdersNet Income | 33.00M | 42.00M | 39.00M | 44.00M | 13.00M | -4.00M | 3.00M | -1.00M | 2.00M | -15.00M | -7.00M | -243.00M | -25.00M | -31.00M | -9.00M | -14.00M | -46.00M | -36.00M | -9.00M | |
| Additional items | ||||||||||||||||||||
| EPS (Basic) | 0.29 | 0.36 | 0.34 | 0.38 | 0.11 | -0.03 | 0.03 | -0.01 | 0.02 | -0.13 | -0.06 | -1.81 | -0.19 | -0.18 | -0.05 | -0.08 | -0.27 | -0.21 | -0.05 | |
| EPS (Diluted) | 0.29 | 0.36 | 0.34 | 0.38 | 0.11 | -0.03 | 0.03 | -0.01 | 0.02 | -0.13 | -0.06 | -1.81 | -0.19 | -0.18 | -0.05 | -0.08 | -0.27 | -0.21 | -0.05 | |
| Shares Outstanding | 115.00M | 115.16M | 115.16M | 115.16M | 115.00M | 115.33M | 116.60M | 116.89M | 116.97M | 116.87M | 117.22M | 117.58M | 134.09M | 133.41M | 168.02M | 168.53M | 168.58M | 168.46M | 169.10M | 169.65M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 115.00M | 115.16M | 115.16M | 115.16M | 115.00M | 115.79M | 119.37M | 119.46M | 116.97M | 119.46M | 117.22M | 117.58M | 134.09M | 133.41M | 168.02M | 168.53M | 168.58M | 168.46M | 169.10M | 169.65M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 115.00M | 115.16M | 115.16M | 115.16M | 116.30M | 116.40M | 116.85M | 116.95M | 117.00M | 117.03M | 117.54M | 117.61M | 160.79M | 133.41M | 163.91M | 163.97M | 164.10M | 164.16M | 164.87M | 164.92M |
| EBITDA | 38.00M | 55.00M | 51.00M | 58.00M | 15.00M | -1.00M | 5.00M | 14.00M | 6.00M | 14.00M | -12.00M | -20.00M | -24.00M | -30.00M | -7.00M | -42.00M | -28.00M | 1.00M | ||
| Interest ExpensesInt Expense | 1.00M | |||||||||||||||||||
| Tax Rate | 13.16% | 23.64% | 23.53% | 25.42% | 13.33% | 33.33% | 100.00% | 50.00% | 66.67% | 50.00% | 28.57% | 12.50% | -0.41% | 24.24% | 20.51% | 10.00% | 6.67% | 9.80% | 26.53% | -12.50% |